Disease Prevention

U.S. flu shot is different this year because one strain has faded during the COVID pandemc

Thu, 2024-10-17 13:06 — mike kraft

The flu shot is different this year, thanks to COVID A strain of influenza appears to have disappeared from the planet since COVID. As a result, U.S. flu vaccines have been redesigned. NPR

This year’s flu shot will be missing a strain of influenza it’s protected against for more than a decade.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. flu shot is different this year because one strain has faded during the COVID pandemc
Log in or register to post comments

Advice on dealing with increasing cases of Whooping cough and walking pneumonia

Thu, 2024-10-17 12:17 — mike kraft

Whooping cough and walking pneumonia cases are up. Here's what to know and how to help keep your family safe. Dr. Jon LaPook talks about the infections on the rise this season, including whooping cough and walking pneumonia. CBS News

Health officials are warning about the rise of multiple infections this season — especially among school-aged children — including whooping cough and walking pneumonia.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Advice on dealing with increasing cases of Whooping cough and walking pneumonia
Log in or register to post comments

Malaria: Nigeria rolls out new Oxford R21 malaria vaccine

Thu, 2024-10-17 11:13 — mike kraft

Nigeria rolls out new Oxford R21 malaria vaccine Nigeria launched a new malaria vaccine on Thursday that will be freely administered to recipients, its health minister said, marking a significant milestone in its fight against the deadly disease. Camillus Eboh Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Malaria: Nigeria rolls out new Oxford R21 malaria vaccine
Log in or register to post comments

Opinion: Veteran government vaccine developer says U.S. response to bird flu outbreak in cattle is ‘frustrating’

Thu, 2024-10-17 10:57 — mike kraft

Veteran vaccine developer says U.S. response to bird flu outbreak in cattle is ‘frustrating’ Barney Graham, a former NIH vaccine developer, said U.S. agencies aren't coordinating the response to the bird flu outbreak among cows. Andrew Joseph STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

How a heavily minority Maryland county initiative successfully improved COVID-19 vaccine rates --study

Wed, 2024-10-16 10:16 — mike kraft

Research initiative successfully combats COVID-19 vaccine disparities An innovative effort to close the gap in COVID-19 vaccination rates in Prince George's County, Maryland found major success, according to new research co-authored by a public health leader at Kennedy ... Kennedy Krieger Institute Medical Xpress

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Situation Report

Novavax's trial of combo COVID-flu shot put on hold because of safety concerns

Wed, 2024-10-16 09:56 — mike kraft

US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after one person who received the shot reported nerve damage, the company said on Wednesday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Novavax's trial of combo COVID-flu shot put on hold because of safety concerns
Log in or register to post comments

Three doses of mRNA COVID vaccine show advantage against severe outcomes --study

Wed, 2024-10-16 09:41 — mike kraft

3 doses of mRNA COVID vaccine show advantage against severe outcomes The authors said COVID-19 infection can result in a "brainstem insult" that results in clusters of physical long-COVID symptoms. CIDRAP

A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially after 4 months.

...

Country / Region Tags:

General Topic Tags: